Study Objectives: To determine the efficacy and toxicity of high-dose hypofractionated proton beam radiotherapy for patients with clinical stage I lung cancer.
Design: A prospective phase 2 clinical trial.
Setting: Loma Linda University Medical Center.
© LitMetric 2025. All rights reserved.